Hyaluronic acid-modified core-shell structured cationic nanocarriers for posterior segment gene therapy
Colloids and Surfaces B: Biointerfaces · 2026
DOI: 10.1016/j.colsurfb.2025.115367 ↗Kurz gefasst
Fachartikel in der Zeitschrift Colloids and Surfaces B: Biointerfaces, 2026. Verfasst von Jiayang Li und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Shenyang Pharmaceutical University, Shenyang 110016, PR China. Hauptthemen laut MEDLINE: Hyaluronic Acid, Genetic Therapy, Nanoparticles, Drug Carriers. Die Arbeit nennt 31 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Effective posterior eye gene delivery remains challenging for neovascular AMD treatment. We developed an intravitreal core-shell nanocarrier with a cationic PβAE dendrimer core (for DNA condensation/endosomal escape), biodegradable PLGA shell (sustained release), and surface HA (vitreal mobility/CD44 targeting). Optimized HA-PP/ND exhibited a uniform size (∼200 nm), high DNA encapsulation efficiency (98 %), and sustained release. In ARPE-19 cells, HA enhanced uptake, lysosomal escape, and transfection efficiency (4.3-fold higher luciferase expression). The carrier delivered antiangiogenic pFlt23K-EGFP, which suppressed VEGF by 48.5 % under hypoxia and inhibited endothelial migration/tube formation. Intravitreally administered HA-PP/N/D reduced CNV lesions by 68 % in a laser-induced wAMD mouse model. This multifunctional platform overcomes ocular gene delivery barriers, providing a promising non-viral strategy for treating posterior segment diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, Shenyang Pharmaceutical University, Shenyang 110016, PR China.
- School of Pharmacy, Shenyang Pharmaceutical University, Shenyang 110016, PR China. Electronic address: wangshujun@syphu.edu.cn.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Li, J., Wang, T., Chen, H., Zhou, X., & Wang, S. (2026). Hyaluronic acid-modified core-shell structured cationic nanocarriers for posterior segment gene therapy. Colloids and Surfaces B: Biointerfaces. https://doi.org/10.1016/j.colsurfb.2025.115367
Vancouver
Li J, Wang T, Chen H, Zhou X, Wang S. Hyaluronic acid-modified core-shell structured cationic nanocarriers for posterior segment gene therapy. Colloids and Surfaces B: Biointerfaces. 2026. doi:10.1016/j.colsurfb.2025.115367
BibTeX
@article{Li2026,
author = {Li, Jiayang and Wang, Tianyi and Chen, Hao and Zhou, Xiaotong and Wang, Shujun},
title = {Hyaluronic acid-modified core-shell structured cationic nanocarriers for posterior segment gene therapy},
journal = {Colloids and Surfaces B: Biointerfaces},
year = {2026},
doi = {10.1016/j.colsurfb.2025.115367}
}
EUVIMED